Cargando…
Escape from Human Immunodeficiency Virus Type 1 (HIV-1) Entry Inhibitors
The human immunodeficiency virus (HIV) enters cells through a series of molecular interactions between the HIV envelope protein and cellular receptors, thus providing many opportunities to block infection. Entry inhibitors are currently being used in the clinic, and many more are under development....
Autores principales: | De Feo, Christopher J., Weiss, Carol D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528295/ https://www.ncbi.nlm.nih.gov/pubmed/23342377 http://dx.doi.org/10.3390/v4123859 |
Ejemplares similares
-
540. Investigating the Mechanism of a Unique Human Immunodeficiency Virus-1 (HIV-1) Entry Inhibitor, MF275
por: Zhao, Connie, et al.
Publicado: (2018) -
Inhibition of Human Immunodeficiency Virus Type 1 Entry by a Keggin Polyoxometalate
por: Wang, Xiaoli, et al.
Publicado: (2018) -
Quantifying the Impact of Human Immunodeficiency Virus-1 Escape From Cytotoxic T-Lymphocytes
por: Kadolsky, Ulrich D., et al.
Publicado: (2010) -
Initial Events in Establishing Vaginal Entry and Infection by Human Immunodeficiency Virus Type-1
por: Hladik, Florian, et al.
Publicado: (2007) -
Resistance to N-peptide fusion inhibitors correlates with thermodynamic stability of the gp41 six-helix bundle but not HIV entry kinetics
por: De Feo, Christopher J, et al.
Publicado: (2014)